SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped ...
SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped read ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈